A Review of Electronic Devices to Track Medication Adherence in Parkinson’s Disease
Objective: The current study set out to compare existing electronic devices (EDs) for tracking medication adherence (MA) and to provide a framework for device selection…Building a Data Base for Automatic Speech Recognition in Parkinson’s disease (PD)
Objective: Describe the rationale and process for acquiring speech data to contribute to increasing accessibility to speech recognition for patients with PD. Background: Disordered speech…The potential impact of physical activity to increase serum a-klotho levels in people with Parkinson’s disease
Objective: To evaluate, summarize and discuss the available literature concerning the potential effect of physical exercise on serum a-klotho levels in people with Parkinson’s disease.…Implementing a Neuropalliative Care Curriculum for Neurology Residents Focused on Neurodegenerative Diseases
Objective: To implement a neuropalliative care curriculum for neurology residents in order to increase comfort with palliative and hospice care topics for patients with progressive…Longitudinal healthcare utilization and costs in Parkinson disease : from pre-diagnosis to 9 years
Objective: The aim of this study was to characterize attributable healthcare utilization and costs in Parkinson disease (PD) in newly diagnosed PD patients managed by…Outcome of Movement Disorders affected by Covid-19: case series from a single Movement Disorders Unit
Objective: The aim of this study is to investigate the effects of corona virus (Covid-19) infection on patients with movement disorders. Background: Since the outbreak…Data Driven Paths to Advancing Precision Medicine Strategies for Parkinson’s Disease: Critical Path for Parkinson’s Consortium
Objective: An update on the accomplishments of the Critical Path for Parkinson’s (CPP) Consortium. Background: The pharmaceutical pipeline for Parkinson’s disease (PD) is rapidly expanding. Data sharing will facilitate decision making during the development…A Milestone-based approach to monitoring disease progression in Parkinson’s disease
Objective: We used Parkinson Progression Marker Initiative (PPMI) data to assess the frequency of clinically meaningful disease milestones and examine baseline predictors of reaching these…Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II clinical trial
Objective: To design a clinical trial to test the concept that the immune system is integral in the progression of Parkinson’s disease (PD) and establish…Efficacy of a 6-week brisk walking program in improving non-motor symptoms in people with Parkinson disease – a randomized controlled trial
Objective: To examine whether the brisk walking program would be effective in alleviating non-motor symptoms, and improving sleep quality and health-related quality-of-life (HRQoL) in people…
- « Previous Page
- 1
- …
- 286
- 287
- 288
- 289
- 290
- …
- 338
- Next Page »